IRIS
MANZIA, TOMMASO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.712
AS - Asia 5.184
EU - Europa 3.115
Continente sconosciuto - Info sul continente non disponibili 667
SA - Sud America 633
AF - Africa 93
OC - Oceania 15
Totale 32.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.511
SG - Singapore 2.705
CN - Cina 832
IT - Italia 699
RU - Federazione Russa 523
BR - Brasile 509
HK - Hong Kong 438
VN - Vietnam 384
DE - Germania 343
FI - Finlandia 266
GB - Regno Unito 247
IE - Irlanda 240
UA - Ucraina 209
BD - Bangladesh 199
FR - Francia 158
JP - Giappone 142
IN - India 140
CA - Canada 112
KR - Corea 104
NL - Olanda 94
SE - Svezia 88
ES - Italia 53
MX - Messico 50
AR - Argentina 48
ID - Indonesia 44
TR - Turchia 42
AT - Austria 40
PL - Polonia 37
BE - Belgio 27
ZA - Sudafrica 24
IQ - Iraq 21
EG - Egitto 20
CO - Colombia 19
EC - Ecuador 19
CZ - Repubblica Ceca 18
AU - Australia 14
CH - Svizzera 14
MY - Malesia 12
NG - Nigeria 12
PH - Filippine 12
GR - Grecia 11
SA - Arabia Saudita 11
CL - Cile 10
KE - Kenya 10
TH - Thailandia 10
HR - Croazia 9
UZ - Uzbekistan 9
IR - Iran 8
JO - Giordania 8
VE - Venezuela 8
EU - Europa 7
JM - Giamaica 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
LT - Lituania 6
MA - Marocco 6
MD - Moldavia 6
PK - Pakistan 6
PY - Paraguay 6
GT - Guatemala 5
HN - Honduras 5
IL - Israele 5
NP - Nepal 5
PE - Perù 5
UY - Uruguay 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
PT - Portogallo 4
RO - Romania 4
TM - Turkmenistan 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
KH - Cambogia 3
KZ - Kazakistan 3
SN - Senegal 3
TW - Taiwan 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
KW - Kuwait 2
LB - Libano 2
ML - Mali 2
MT - Malta 2
NO - Norvegia 2
PA - Panama 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
Totale 31.739
Salva come PNG Salva come JPEG
Città #
Wilmington 5.240
Houston 4.832
Woodbridge 4.195
Singapore 1.240
Fairfield 770
Ashburn 648
San Jose 538
Ann Arbor 470
New York 459
Chandler 438
Hong Kong 423
Council Bluffs 345
Beijing 344
Seattle 308
Cambridge 281
Santa Clara 246
Dublin 231
Helsinki 200
Los Angeles 181
Medford 178
Jacksonville 173
The Dalles 154
Rome 139
Tokyo 128
Ho Chi Minh City 118
Buffalo 105
Zhengzhou 101
Hanoi 94
Elk Grove Village 88
Moscow 84
Lawrence 83
Lauterbourg 78
Dearborn 72
São Paulo 68
Chicago 62
Orem 58
Boardman 54
Milan 54
San Diego 51
Dallas 46
Creede 45
London 43
North Bergen 43
Munich 41
Chennai 40
Atlanta 38
Menlo Park 34
Montreal 32
Shanghai 31
Jakarta 30
Denver 29
Frankfurt am Main 28
Mülheim 28
Toronto 28
Brooklyn 27
Warsaw 26
Nuremberg 24
Manchester 23
Nanjing 23
Amsterdam 22
Johannesburg 22
Palo Alto 22
Poplar 22
Redondo Beach 22
Lappeenranta 21
Phoenix 21
Stockholm 21
Turin 21
Vienna 21
Brussels 20
Mexico City 18
San Francisco 18
Mountain View 16
Norwalk 16
Redwood City 16
Salt Lake City 16
Seoul 16
Verona 16
Jersey City 15
Rio de Janeiro 15
Dong Ket 14
Miami 14
Washington 14
Ankara 13
Hefei 13
Madrid 13
Brasília 12
Engelhard 12
Guangzhou 12
Columbus 11
Genoa 11
Istanbul 11
Mumbai 11
Padua 11
Da Nang 10
Haiphong 10
Naples 10
Boston 9
Curitiba 9
Hounslow 9
Totale 24.616
Salva come PNG Salva come JPEG
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 686
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 537
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 530
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 509
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 508
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 501
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 493
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 491
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 488
Use of mycophenolate mofetil in liver transplantation: a literature review. 487
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 487
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 477
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Marginal donors in liver transplantation. 475
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 473
596 464
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 461
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 453
Management of spermatic cord liposarcoma in renal transplant recipients: case report 449
Liver abscess caused by foreign body ingestion 449
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 446
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 446
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 439
Immunosuppression-Free Liver Transplantation 438
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 434
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 433
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 433
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 423
Liver transplantation for the treatment of nodular regenerative hyperplasia 423
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 423
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 420
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 417
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 417
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 408
Prospect for kidney bioengineering: Shortcomings of the status quo 393
Myopericytoma of the Liver Hilus: A Case Report 385
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 382
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 376
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 368
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 368
An unusual duodenal polyp causing anemia in a liver-transplanted patient 350
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 341
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 334
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 334
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 325
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 315
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 311
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 303
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 303
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 292
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 282
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 263
Pandora’s Box: Unpredictable Evolution of a 20-Year History of a Bariatric Patient—Report of Small Bowel Migrated Gastric Band after Redo Banded Gastric Bypass 258
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 253
Rare malignant glomus tumor of the stomach with liver metastases 238
Platelets and hepatocellular cancer: Bridging the bench to the clinics 230
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 226
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 224
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 216
Liver transplantation for hepatocellular carcinoma: Where do we stand? 211
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 209
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 208
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report 203
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 203
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 202
Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome 198
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 197
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 197
Abdominal organ bioengineering: current status and future perspectives 181
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 177
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 176
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 161
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group 158
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 138
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 136
Moving forward in the treatment of cholangiocarcinoma 132
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation 122
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 120
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 116
Chronic rejection after liver transplantation: Opening the Pandora's box 110
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 109
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 108
Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis 105
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 104
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 103
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant 101
Intraductal Papillary Neoplasms of the Bile Duct: Clinical Case Insights and Literature Review 99
Cancer mortality after kidney transplantation: A multicenter cohort study in Italy 98
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 97
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 96
Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation 95
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 95
Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese patients with end-stage liver disease: the LT-SG study 94
High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up 94
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 92
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 91
Cell transplantation-based regenerative medicine in liver diseases 91
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 91
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 90
Temporal trends of waitlistings for liver transplantation in Italy: the ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study 89
Totale 29.060
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022845 0 87 14 32 24 92 61 28 114 112 54 227
2022/20231.362 137 118 15 144 106 247 106 250 100 12 92 35
2023/2024676 76 38 81 17 93 163 32 12 16 37 8 103
2024/20254.082 93 753 446 230 39 283 305 115 324 339 665 490
2025/20267.116 587 285 621 669 683 444 890 895 801 566 389 286
2026/2027586 327 259 0 0 0 0 0 0 0 0 0 0
Totale 32.419